Tau-萎缩变异性揭示阿尔茨海默病的表型异质性
研究在104个灰质区计算认知障碍且淀粉样蛋白阳性个体的皮层厚度(N)与18F-Flortaucipir SUVR(T),以稳健线性拟合残差作为T-N不匹配指标。该指标与年龄及白质高信号负荷相关,基于残差聚类可分出具有不同萎缩空间模式的生物学表型。
要点
- T-N不匹配指标可量化Tau与萎缩关系的个体差异。
- 该指标与年龄和白质高信号负荷相关。
- 残差聚类可识别不同萎缩空间模式的表型。
核心结论
- Tau负荷与神经退行性变关系的区域偏差可反映多种因素导致的变异性,并揭示潜在表型。
研究设计与样本
- 研究纳入认知障碍且淀粉样蛋白阳性个体,在104个灰质区计算皮层厚度与18F-Flortaucipir SUVR,以稳健线性拟合残差作为T-N不匹配替代指标。
主要发现
- 汇总T-N不匹配指标与年龄及白质高信号病变负荷相关。
- 基于残差聚类的数据驱动亚组呈现不同的高于或低于预期萎缩的空间模式。
临床怎么用
- 该T-N不匹配指标或有助于识别Tau之外参与神经退行性变的因素,并可能用于临床试验队列选择。
局限性
- 原文未报告具体样本量、阈值、P值等数值细节。
- 表型需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Tau neurofibrillary tangles (T) are the primary driver of downstream neurodegeneration (N) and subsequent cognitive impairment in Alzheimer's disease (AD). However, there is substantial variability in the T-N relationship - manifested in higher or lower atrophy than expected for level of tau in a given brain region. The goal of this study was to determine if region-based quantitation of this variability allows for identification of underlying modulatory factors, including polypathology. METHODS: Cortical thickness (N) and 18 F-Flortaucipir SUVR (T) were computed in 104 gray matter regions from a cohort of cognitively-impaired, amyloid-positive (A+) individuals. Region-specific residuals from a robust linear fit between SUVR and cortical thickness were computed as a surrogate for T-N mismatch. A summary T-N mismatch metric defined using residuals were correlated with demographic and imaging-based modulatory factors, and to partition the cohort into data-driven subgroups. RESULTS: The summary T-N mismatch metric correlated with underlying factors such as age and burden of white matter hyperintensity lesions. Data-driven subgroups based on clustering of residuals appear to represent different biologically relevant phenotypes, with groups showing distinct spatial patterns of higher or lower atrophy than expected. INTERPRETATION: These data support the notion that a measure of deviation from a normative relationship between tau burden and neurodegeneration across brain regions in individuals on the AD continuum captures variability due to multiple underlying factors, and can reveal phenotypes, which if validated, may help identify possible contributors to neurodegeneration in addition to tau, which may ultimately be useful for cohort selection in clinical trials. ANN NEUROL 2021;90:751-762.
引用
- Das SR, Lyu X, Duong MT, et al. Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease. Ann Neurol. 2021. PMID: 34617306. doi:10.1002/ana.26233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。